Targeting Metabolic Flexibility in Amyotrophic Lateral Sclerosis (ALS)

NCT04788745 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis
Motor Neuron Disease

Interventions

DRUG: Trimetazidine Dihydrochloride

Sponsor

The University of Queensland

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]